Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDICLAS Study
NCT00122226Phase 4Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised trial of nevirapine, zidovudine and lamivudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Insulin Resistance at 36 months, Microvascular Function at 36 months and 3 more. Status: unknown.
02
Drugs
nevirapinezidovudinelamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00122226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00122226.